stocks logo

CTMX Financial Analysis

CytomX Therapeutics Inc
$
0.409
-0.046(-10.100%)

CTMX Financial Analysis

FY2024Q3FY2024Q2FY2024Q1FY2023Q4FY2023Q3FY2023Q2FY2023Q1FY2022Q4FY2022Q3FY2022Q2FY2022Q1FY2021Q4FY2021Q3FY2021Q2FY2021Q1FY2020Q4FY2020Q3FY2020Q2FY2020Q1
Net Cash Flow from Operating Activities
-20.73M
13.63%
-19.55M
-22.36%
-26.05M
-378.59%
-21.96M
1475.54%
-18.24M
-46.10%
-25.18M
-26.46%
9.35M
-122.63%
-1.39M
-95.53%
-33.84M
13.95%
-34.24M
21.41%
-41.31M
37.99%
-31.19M
78.99%
-29.70M
20.35%
-28.20M
-129.04%
-29.94M
-39.80%
-17.43M
-40.88%
-24.68M
5.83%
97.10M
-299.58%
-49.74M
Funds from Operations
7.97M
114.82%
-4.62M
-523.65%
15.29M
-1724.34%
2.61M
-111.05%
3.71M
-119.40%
1.09M
-105.98%
-941.00K
-95.07%
-23.64M
-55.79%
-19.13M
6.62%
-18.26M
28.33%
-19.10M
74.53%
-53.48M
601.06%
-17.94M
75.16%
-14.23M
21.27%
-10.95M
-165.44%
-7.63M
-75.40%
-10.24M
-46.74%
-11.73M
-46.51%
16.73M
Change in Working Capital
-28.70M
30.73%
-14.93M
-43.18%
-41.33M
-501.65%
-24.58M
-210.45%
-21.95M
49.20%
-26.27M
64.38%
10.29M
-146.33%
22.25M
-0.16%
-14.71M
25.15%
-15.98M
14.37%
-22.21M
16.93%
22.29M
-327.42%
-11.76M
-18.55%
-13.97M
-112.84%
-18.99M
-71.42%
-9.80M
-743.40%
-14.43M
253.26%
108.83M
-507.29%
-66.47M
Net Cash Flow from Investing Activities
18.17M
-142.31%
21.51M
-17.39%
44.89M
-130.61%
12.87M
-87.11%
-42.94M
10372.68%
26.04M
-6420.39%
-146.64M
19824.18%
99.82M
-40842.04%
-410.00K
-104.21%
-412.00K
-99.10%
-736.00K
-101.25%
-245.00K
-101.26%
9.73M
-110.81%
-46.01M
-193.04%
59.01M
2317.53%
19.46M
-63.19%
-90.07M
-333.88%
49.45M
612.58%
2.44M
Capital Expenditures - Net
19.00K
111.11%
96.00K
-81.43%
115.00K
139.58%
266.00K
46.15%
9.00K
-97.80%
517.00K
25.49%
48.00K
-93.48%
182.00K
-25.71%
410.00K
52.99%
412.00K
261.40%
736.00K
-25.05%
245.00K
-44.94%
268.00K
-65.55%
114.00K
208.11%
982.00K
-6.39%
445.00K
-36.70%
778.00K
23.89%
37.00K
-88.82%
1.05M
Net Cash Flow from Financing Activities
0.00
-100.00%
5.10M
1508.52%
174.00K
244.00K
28.42%
29.67M
317.00K
-29.71%
0.00
-100.00%
190.00K
-72.18%
0.00
-100.00%
451.00K
-34.73%
7.00K
-99.99%
683.00K
-94.75%
104.00K
-37.72%
691.00K
-55.36%
108.74M
4941.03%
13.02M
3147.13%
167.00K
165.08%
1.55M
121.78%
2.16M
Stock - Total - Issuance/(Retirement) - Net
0.00
-100.00%
5.10M
1508.52%
174.00K
244.00K
29.67M
317.00K
-29.71%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
451.00K
-34.73%
7.00K
-99.99%
683.00K
-94.75%
104.00K
-37.72%
691.00K
-55.36%
108.74M
4941.03%
13.02M
3147.13%
167.00K
165.08%
1.55M
121.78%
2.16M
Net Change in Cash
-2.56M
-91.87%
7.06M
498.98%
19.01M
-113.85%
-8.85M
-108.98%
-31.51M
-8.00%
1.18M
-103.45%
-137.29M
226.56%
98.61M
-420.65%
-34.25M
72.46%
-34.20M
-53.48%
-42.04M
-130.51%
-30.75M
-304.36%
-19.86M
-82.67%
-73.52M
-149.64%
137.81M
-405.29%
15.05M
-36.71%
-114.58M
-851.13%
148.10M
-461.09%
-45.14M
Free Cash Flow
-20.75M
13.68%
-19.65M
-23.55%
-26.16M
-381.26%
-22.23M
1310.47%
-18.25M
-46.72%
-25.70M
-25.84%
9.30M
-122.12%
-1.58M
-94.99%
-34.25M
14.30%
-34.65M
22.38%
-42.05M
35.98%
-31.44M
75.90%
-29.97M
17.72%
-28.31M
-129.17%
-30.92M
-39.11%
-17.87M
-40.79%
-25.46M
6.30%
97.06M
-298.15%
-50.79M

CTMX FAQs

What is CTMX's PE Ratio in 2025/4/4?

CTMX's PE ratio in April 4, 2025 is 1.21. This indicates the price investors are willing to pay for $1 of earnings.

What is CTMX's PS Ratio in 2025/4/4?

What is CTMX's Dividend Yield in 2024/Q3?

What is CTMX's Gross Margin in 2024/Q3?

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

Is CTMX earnings result positive or negative?How should I trade on CTMX earnings?